Russell Investments Group
SILK

Russell Investments Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Russell Investments Group’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-387
Closed -$10.5K – 3835
2024
Q2 		$10.5K Sell
387
-44,606
-99% -$928K ﹤0.01% 3064
2024
Q1 		$824K Buy
44,993
+44,647
+12,904% +$709K ﹤0.01% 2039
2023
Q4 		$4.25K Buy
+346
New +$3.25K ﹤0.01% 2925
2023
Q1 		– Sell
-47,894
Closed -$2.53M – 3414
2022
Q4 		$2.53M Buy
+47,894
New +$2.33M 0.01% 1442
2021
Q3 		– Sell
-19,110
Closed -$914K – 3252
2021
Q2 		$914K Buy
+19,110
New +$974K ﹤0.01% 2354
2021
Q1 		– Sell
-4,900
Closed -$308K – 3208
2020
Q4 		$308K Buy
+4,900
New +$304K ﹤0.01% 2614
2020
Q3 		– Sell
-13,300
Closed -$557K – 3269
2020
Q2 		$557K Buy
+13,300
New +$511K ﹤0.01% 2344

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's SILK Position: Q3 2024 in Review

Russell Investments Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 387 shares — an estimated $10.5K sold.

Russell Investments Group first reported a position in SILK in Q2 2020 and held it in 7 quarters. The position peaked at $2.53M in Q4 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Russell Investments Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 387 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $10.5K.
  • Russell Investments Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Russell Investments Group's Silk Road Medical, Inc. Common Stock position peaked at $2.53M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.